Home/Filings/4/0001654954-22-000130
4//SEC Filing

Mazar Andrew Paul 4

Accession 0001654954-22-000130

CIK 0001645469other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 2:49 PM ET

Size

10.6 KB

Accession

0001654954-22-000130

Insider Transaction Report

Form 4
Period: 2022-01-01
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-01+1,93721,660.8 total
  • Tax Payment

    Common Stock

    2022-01-01$3.21/sh671$2,15420,989.8 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-01-011,9373,874 total
    Common Stock (1,937 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    4,111,272.88
  • Common Stock

    (indirect: See footnote)
    166,667
Footnotes (4)
  • [F1]Represents shares acquired on vesting and settlement of restricted stock units.
  • [F2]This is based upon the 4,111,272.88 shares of Monopar Common Stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Dr. Mazar may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Dr. Mazar disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
  • [F3]This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Dr. Mazar may be deemed to share voting and dispositive power over these 166,667 shares. Dr. Mazar disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
  • [F4]On January 31, 2020 the reporting person was granted 7,748 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001727393

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 2:49 PM ET
Size
10.6 KB